Founder and CEO of @Arda_Tx. Aging biologist, in all senses of the phrase.
Joined May 2009
- Tweets 39
- Following 258
- Followers 546
- Likes 47
Photos and videos
11 Feb 2025
If you are a scientist, investor, or potential business partner interested in longevity biotech, this is an up-to-date overview of leading companies in the space, including @Arda_Tx. Nice job @HealthspanCap
11 Feb 2025
1/ 🚀 Excited to announce the release of our LongBio Report 2025 —comprehensively profiling the leading companies in longevity biotechnology. This is your guide to understanding the future of healthy lifespan extension.
👉Read the report: healthspancapital.vc/longbio…
1
3
333
Adam Freund retweeted
30 Oct 2024
Arda’s founders, CEO @Adam_M_Freund and CTO Rémi Laberge, joined the @BioAgePodcast to explore Arda's cutting-edge approach to treating chronic diseases. Adam and Remi discussed Arda’s origin and shared how the company's single-cell-based discovery platform pinpoints pathogenic cells in conditions like fibrosis, allowing for targeted cell depletion instead of traditional pathway modification. They described the challenges and opportunities inherent to applying the immune-oncology toolbox to non-oncology diseases, and outlined their vision for antibody-based therapeutics that could offer long-lasting effects with intermittent dosing, improving patient quality of life and paving the way for future applications in aging.
30 Oct 2024
This week, we talk with the founders of @Arda_Tx about their innovative approach to developing therapeutics: eliminating the pathogenic cell types that drive chronic disease.
Episode: player.captivate.fm/episode/…
4
6
612
9 Oct 2024
9 Oct 2024
Huge congrats to @Adam_M_Freund, Rémi Laberge, @ScottTu85994558 and the rest of the @Arda_Tx team on the announcement of their Series A financing to advance a new wave of cell depletion medicines.
@vintweeta and I have had the pleasure of supporting @Arda_Tx since inception. More on our investment thesis here: a16z.com/announcement/invest…
1
164
9 Oct 2024
A wonderful day here at @Arda_Tx. $43M to continue advancing our pipeline, developing our platform, and exploring the potential of pathogenic cell depletion to treat chronic diseases!
Come build with us: ardatx.com/careers.
9 Oct 2024
Arda is pleased to announce the closing of our $43M Series A financing to accelerate the development of precision cell-depleting biologics to treat chronic diseases!
The new capital will be used to drive our existing I&I pipeline toward the clinic, expand into new indications, and scale our single cell discovery platform.
Thank you to our investors @a16zBioHealth, @TwoSigmaVC , @EliLillyandCo, @GVteam, @alumniventures, @exitfundvc, @GaingelsVC, @IndicatorVC, @Mana_Ventures, @hello_valhalla, RV Invest, Biovision Ventures, and LifeLink Ventures.
Learn more about our mission to deplete pathogenic cells to treat disease at ardatx.com
businesswire.com/news/home/2…
1
8
369
Adam Freund retweeted
6 May 2024
We're thrilled to announce that Scott Turner (@ScottTu85994558) has joined us as Arda's new Chief Scientific Officer! Scott brings a wealth of experience and expertise in the development and translation of anti-fibrotic therapies from his former role as CSO at @PliantRX. Welcome!
1
3
340
Adam Freund retweeted
21 Dec 2023
Help save the Dog Aging Project.
Despite being one of the most influential, productive and impactful NIH supported projects over the past 5 years, the National Institute on Aging has inexplicably chosen to withdraw support for the Dog Aging Project. For now, I’m won't get into the details of the process or my personal feelings about it, as the important thing is to ensure the Dog Aging Project doesn’t end. If you believe that the Dog Aging Project has value and should continue, I have three requests of you:
(1) Please consider signing the petition to the NIH Director here: actionnetwork.org/petitions/…
(2) Please consider sending an email to your elected representatives here: actionnetwork.org/letters/su…
(3) Please share this message with your network as broadly as you can
Thank you!!!
60
271
542
206,534
4 Aug 2023
This is our first job opening in several months, and likely our last for a few more months!
4 Aug 2023
A great opportunity for a scientist with biotech/pharma industry experience to contribute individually, lead projects, mentor colleagues, and grow their career. Come build with us!
linkedin.com/jobs/view/36808…
7
13
3,910
Adam Freund retweeted
5 Jun 2023
The new Arda website is live at ardatx.com. Check it out to learn about our science, our incredible team, and more!
1
4
462
28 Feb 2023
In the short story “Harrison Bergeron”, Vonnegut describes an earpiece radio that broadcasts a loud noise every 20 seconds or so in order to destroy people’s ability to think clearly. 👇
1
2
9
1,298
28 Feb 2023
I remember reading that story in high school and thinking “that wouldn't work, people would just wait until the sound stopped and pick up their train of thought where they left off”.
And now I have young children. And, I realize, so did Vonnegut. And we both know better.
10
299
22 Feb 2023
Glad to see longevity research starting to pervade the halls of Congress. Nice work @TheA4li team!
A4LI is proud to announce the founding of the Congressional Caucus for Longevity Science. The formation of the “Longevity Science Caucus” is a transformational moment for the longevity biotechnology industry and the movement to increase healthy human lifespans.
1
5
405
24 Jan 2023
Thanks for a nice discussion, @TGrantBelgard and the @BioinfoCRO team!
24 Jan 2023
Check out our interview with @afreund83, founder and CEO of @Arda_Tx
bioinformaticscro.com/podcas…
4
291
2 Nov 2022
This will be a symposium to remember! The speaker lineup includes stellar scientists, energetic entrepreneurs, driven drug developers...and me, apparently the abbot of aggressive alliteration.
30 Oct 2022
Get your tix for longevitysummit.io
@BuckInstitute Dec 6-7. Stellar speakers including @celinehalioua @ashleyz413 @DrMorganLevine @mkaeberlein @apollohealthvc @JamesPeyer @bioagelabs @CharlesMBrenner @andy_d_lee @Dr_Behrouz @jenngarrison @glycanage @realNathanCheng
5
8
25 Jul 2022
Today, @Arda_Tx's bench gets deeper. Welcome Martin!
25 Jul 2022
Arda is delighted to welcome Martin Preyer to the team as our Vice President, Biologics! Martin is an antibody engineering expert and will oversee the generation, characterization, and optimization of novel therapeutics that target and eliminate pathogenic cell populations.
2
Adam Freund retweeted
19 Jul 2022
Arda's team is expanding! We've opened two new computational roles: a computational biologist and a data engineer. Bring your single cell analysis chops and help us make drugs that target cells, not pathways. ardatx.notion.site/ardatx/Jo….
4
4
14 Apr 2022
Our preprint is now published in eLife (lnkd.in/gMPW7njr)! This is the culmination of a project I started @calico, to create a system for preclinical testing of aging interventions at scale, (1/8)
5
14
74
14 Apr 2022
We're proud of what we built here, but by no means is it the only system that can be used to measure organismal aging. What's more important than the exact sensors used is the high dimensional, automated framework. (7/8)
1
3
14 Apr 2022
As I've argued before (sciencedirect.com/science/ar…), this framework is key to shaking off the "what is 'real' aging?" mindset and identifying interventions with the biggest impact on overall health and highest likelihood of clinical translation. (8/8)
1
8